AIMS: To characterize mutants of Staphylococcus aureus expressing reduced susceptibility to house cleaners (HC), assess the impact of the alternative sigma factor SigB on HC susceptibility, and determine the MIC of clinical methicillin-resistant S. aureus (MRSA) to a HC. METHODS AND RESULTS: Susceptibility to HC, HC components, H2O2, vancomycin and oxacillin and physiological parameters were determined for HC-reduced susceptibility (HCRS) mutants, parent strain COL and COLsigB::kan. HCRS mutants selected with three HC expressed reduced susceptibility to multiple HC, HC components, H2O2 and vancomycin. Two unique HCRS mutants also lost the methicillin resistance determinant. In addition, all HCRS mutants exhibited better growth at two temperatures, and one HCRS mutant expressed reduced carotenoid production. COLsigB::kan demonstrated increased susceptibility to all HC and many HC components. sigB operon mutations were not detected in one HCRS mutant background. Of 76 clinical MRSA, 20 exhibited reduced susceptibility to a HC. CONCLUSIONS: HCRS mutants demonstrate altered susceptibility to multiple antimicrobials. While sigB is required for full HC resistance, one HCRS mechanism does not involve sigB operon mutations. Clinical MRSA expressing reduced susceptibility to a common HC were detected. SIGNIFICANCE AND IMPACT OF THE STUDY: This study suggests that HCRS mutants are not protected against, nor selected by, practical HC concentrations.
AIMS: To characterize mutants of Staphylococcus aureus expressing reduced susceptibility to house cleaners (HC), assess the impact of the alternative sigma factor SigB on HC susceptibility, and determine the MIC of clinical methicillin-resistant S. aureus (MRSA) to a HC. METHODS AND RESULTS: Susceptibility to HC, HC components, H2O2, vancomycin and oxacillin and physiological parameters were determined for HC-reduced susceptibility (HCRS) mutants, parent strain COL and COLsigB::kan. HCRS mutants selected with three HC expressed reduced susceptibility to multiple HC, HC components, H2O2 and vancomycin. Two unique HCRS mutants also lost the methicillin resistance determinant. In addition, all HCRS mutants exhibited better growth at two temperatures, and one HCRS mutant expressed reduced carotenoid production. COLsigB::kan demonstrated increased susceptibility to all HC and many HC components. sigB operon mutations were not detected in one HCRS mutant background. Of 76 clinical MRSA, 20 exhibited reduced susceptibility to a HC. CONCLUSIONS: HCRS mutants demonstrate altered susceptibility to multiple antimicrobials. While sigB is required for full HC resistance, one HCRS mechanism does not involve sigB operon mutations. Clinical MRSA expressing reduced susceptibility to a common HC were detected. SIGNIFICANCE AND IMPACT OF THE STUDY: This study suggests that HCRS mutants are not protected against, nor selected by, practical HC concentrations.
Authors: E C Cole; R M Addison; J R Rubino; K E Leese; P D Dulaney; M S Newell; J Wilkins; D J Gaber; T Wineinger; D A Criger Journal: J Appl Microbiol Date: 2003 Impact factor: 3.772
Authors: Malcolm J Horsburgh; Joanne L Aish; Ian J White; Les Shaw; James K Lithgow; Simon J Foster Journal: J Bacteriol Date: 2002-10 Impact factor: 3.490
Authors: Margaret Edmondson; Nelly Newall; Keryln Carville; Joanna Smith; Thomas V Riley; Christine F Carson Journal: Int Wound J Date: 2011-05-12 Impact factor: 3.315
Authors: Vineet K Singh; Sirisha Sirobhushanam; Robert P Ring; Saumya Singh; Craig Gatto; Brian J Wilkinson Journal: J Med Microbiol Date: 2018-03-02 Impact factor: 2.472
Authors: Jesus A Cuaron; Santosh Dulal; Peter H Cooke; Nathanial J Torres; John E Gustafson Journal: Phytother Res Date: 2014-02-12 Impact factor: 5.878
Authors: R Lamichhane-Khadka; J T Riordan; A Delgado; A Muthaiyan; T D Reynolds; B J Wilkinson; J E Gustafson Journal: J Appl Microbiol Date: 2008-12 Impact factor: 3.772
Authors: James T Riordan; JoAnne M Dupre; Stephanie A Cantore-Matyi; Atul Kumar-Singh; Yang Song; Shahrear Zaman; Sonia Horan; Nada S Helal; Vijayaraj Nagarajan; Mohamed O Elasri; Brian J Wilkinson; John E Gustafson Journal: Ann Clin Microbiol Antimicrob Date: 2011-07-21 Impact factor: 3.944